Theories of epidemiology, health behaviour, and social science have changed the
understanding of HIV prevention in the past three decades. The HIV prevention cascade is …

When used appropriately, pre-exposure prophylaxis (PrEP) substantially reduces the risk of
HIV acquisition. Early implementation outcomes often suggest poor PrEP adherence and …

Background COVID-19 has the potential to cause substantial disruptions to health services,
due to cases overburdening the health system or response measures limiting usual …

Background Operational research is required to design delivery of pre-exposure prophylaxis
(PrEP) and early antiretroviral treatment (ART). This paper presents the primary analysis of …

Background There is concern that the COVID-19 pandemic could severely disrupt HIV
services in sub-Saharan Africa. However, it is difficult to determine priorities for maintaining …

Abstract Design Universal voluntary HIV counselling and testing followed by prompt
initiation of antiretroviral therapy (ART) for all those diagnosed HIV‐infected (universal test …

Pre-exposure prophylaxis (PrEP) for HIV prevention has evolved significantly over the years
where clinical trials have now demonstrated the efficacy of oral PrEP, and the field is scaling …

COVID-19 has the potential to cause disruptions to health services in different ways; through
the health system becoming overwhelmed with COVID-19 patients, through the intervention …

Abstract Introduction In sub-Saharan Africa, considerable HIV-burden exists among women.
Anti-retroviral (ARV) based prevention products could decrease this burden, and their …

Background Although effective, some oral pre-exposure prophylaxis (PrEP) users face
barriers to adherence using daily pills, which could be reduced by long-acting formulations …